Viridian Therapeutic (VRDN) PT Lowered to $28 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts VRDN Hot Sheet
Price: $29.06 --0%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 2
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 2
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $28.00 (from $31.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Joby Aviation Inc (JOBY) PT Lowered to $10 at Needham
- Magnite (MGNI) PT Raised to $35 at Susquehanna
- Shenzhen Kstar Science & Tech (002518:CH) PT Lowered to RMB38 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
